Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease
P.M. Burger(University Medical Center Utrecht), Jeroen Schaap, Alison Morton, Deepak L. Bhatt(Mount Sinai Hospital), Alan Whelan, Randall Hendriks, Jan H. Cornel(Brigham and Women's Hospital), Aernoud T.L. Fiolet(University Medical Center Utrecht), Xianfan Xu(Purdue University West Lafayette), I. C. D. Westendorp(Red Cross Hospital), Folkert W. Asselbergs(Health Data Research UK), A. Jerzewski, Maarten J. Cramer(SUNY Downstate Health Sciences University), Driek Beelen(IJsselland Ziekenhuis), Arend Mosterd(Werkgroep Cardiologische centra Nederland), Shirley Jansen(Harry Perkins Institute of Medical Research), P.R. Nierop, P. Salkani, Martin Teraa(Maine Farmland Trust), Marjo S. van der Knaap(Amsterdam Neuroscience), Charley Budgeon(The University of Western Australia), Jannick A N Dorresteijn(Utrecht University), Stefan M. Nidorf(Harry Perkins Institute of Medical Research), Benjamin King, Frank L.J. Visseren(University Medical Center Utrecht), Stefan Koudstaal, Fabrice M A C Martens(Deventer Ziekenhuis), Timo Lenderink, John W. Eikelboom(Population Health Research Institute), Anna Thompson, H. Bakker-Lohmeijer, Petra Bunschoten, Peter L. Thompson(Sir Charles Gairdner Hospital), I.W. Tan, R Lardinois, H. Swart, Alex de Vos, B Hockings, Pieter Hoogslag, R. Kingma, Salem H.K. The, M. A. Ireland, Philip Thompson(The Heart Research Institute), Donald Latchem, S. van der Kooi, Philippe Gabríel Steg(Mount Sinai Hospital)
Cited by 16
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k